Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102229723 | 10222972 | 3 | F | 20160627 | 20140607 | 20160705 | EXP | PHHY2014AT069423 | NOVARTIS | 0.00 | A | M | Y | 106.00000 | KG | 20160705 | OT | AT | AT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102229723 | 10222972 | 1 | PS | STI571 | IMATINIB MESYLATE | 1 | Unknown | 400 MG, UNK | U | 21588 | 400 | MG | |||||||
| 102229723 | 10222972 | 2 | SS | TASIGNA | NILOTINIB | 1 | Unknown | LESS THAN 400 MG, TWICE DAILY (BID) | U | 0 | CAPSULE | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102229723 | 10222972 | 1 | Chronic myeloid leukaemia |
| 102229723 | 10222972 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102229723 | 10222972 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102229723 | 10222972 | Dyspnoea | |
| 102229723 | 10222972 | Interstitial lung disease | |
| 102229723 | 10222972 | Lung disorder | |
| 102229723 | 10222972 | Obesity | |
| 102229723 | 10222972 | Pain in extremity | |
| 102229723 | 10222972 | Polyneuropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |